Abstract-Brachial-ankle pulse wave velocity (baPWV) has been proposed as a simple, noninvasive method for estimating arterial stiffness. Although high baPWV was predictive of cardiovascular mortality and morbidity among general population, its predictive value for mortality in patients with acute stroke is unknown. We evaluated the prognostic value of baPWV in 1765 patients who had been admitted for acute ischemic stroke and had completed measurement of baPWV during admission. Primary outcomes were all-cause mortality and vascular mortality (death because of heart diseases, cerebrovascular diseases, or diseases of arteries, arterioles, and capillaries, determined according to the International Classification of Diseases) after stroke. During a mean follow-up period of 3.33±1.57 years, there were 228 all-cause deaths, including 143 vascular deaths. In multivariate Cox hazard regression, patients in the highest tertile of baPWV (>22.63 m/s) were at an increased risk for both all-cause death (adjusted hazard ratio, 1.97; 95% confidence interval, 1.25-3.08) and vascular death (adjusted hazard ratio, 2.39; 95% confidence interval, 1.33-4.29) compared with the lowest tertile (<17.79 m/s). This study suggested that measurement of baPWV during the acute phase of stroke might be useful in identifying patients at a higher risk for mortality. 
A rterial stiffness increases with aging and has been suggested as a surrogate marker of atherosclerosis and an independent cardiovascular risk factor. [1] [2] [3] Measurement of carotid-femoral pulse wave velocity (cfPWV) is considered a gold standard method for assessing central artery stiffness. 4 Elevated cfPWV is associated with traditional risk factors such as hypertension, diabetes mellitus, inflammatory conditions, and disease of the coronary, peripheral, cerebral arteries, and aorta. 3, 5, 6 Furthermore, cfPWV has prognostic value in the development of hypertension, coronary heart disease, heart failure, stroke, and increased mortality. 1, 2, 7 Brachial-ankle PWV (baPWV) is an alternatively developed technique to assess arterial stiffness. 4, 8 baPWV is widely used in clinical practice because baPWV provides an automated method and is more simple to use compared with cfPWV. The value of baPWV has been shown to be reproducible and well correlated with that of cfPWV. 4, 9 Recent longitudinal studies demonstrated that baPWV levels also have a significant predictive value for cardiovascular mortality and morbidity among high-risk patients and general population. 8, 10 Patients with stroke have an increased arterial stiffness compared with those who have not suffered stroke. 6 In recent studies, measurement of arterial stiffness (cfPWV or baPWV) during the acute phase of stroke showed significant prognostic value for predicting early neurological deterioration and poor functional outcome. [11] [12] [13] However, the prognostic value for long-term mortality of arterial stiffness measured in patients with acute stroke remains unknown. Therefore, we investigated whether the baPWV measured during acute ischemic stroke has a predictive value for all-cause and vascular mortality.
Methods

Study Population
Study patients were those admitted for acute ischemic stroke ≤7 days of symptom onset between July 2006 and September 2011 and who were prospectively registered in the Yonsei Stroke Registry.
14 The registry includes patients admitted for acute stroke to the stroke center of the Yonsei University Severance Hospital. The Yonsei University Severance Hospital is a 2000-bed teaching hospital located in the western portion of Seoul, the capital and largest city of South Korea. Approximately 80% of patients admitted with stroke are from Seoul and adjacent Gyeonggi province and whose demographic characteristics are comparable with those of urban populations in large metropolitan areas. 15 The stroke center has received certificate from the Joint Commission International (http://www.jointcommissioninternational.org) for Clinical Care Program Certification for primary stroke since April 24, 2010 .
We excluded patients with in-hospital stroke (patients who developed stroke during admission for other illnesses), a history of cancer, and stroke of other determined causes based on the Trial of Org 10172 in the Acute Stroke Treatment (TOAST) classification, because these conditions were considered possible confounders for long-term mortality. 16 We included only patients who completed measurement of baPWV and cerebral angiography ≤7 days from admission. The Institutional Review Board of Severance Hospital, Yonsei University Health System, approved this study and waived the need for informed consent because of the observational nature of the study.
Measurement of PWV and Blood Pressure
baPWV and ankle-brachial index were obtained by 1 measurement ≤7 days from admission in the supine position using an automated device (VP-1000; Colin Co. Ltd, Komaki, Japan), which has been validated previously. 9, 17 This device simultaneously measures arterial pulse waves and systolic/diastolic arterial pressures in both the brachial and posterior tibial arteries using the oscillometric method. 9 Transmission time for travel between the right arm and both ankles was calculated using the waveform. The transmission distance between the right brachium and ankle was automatically calculated according to the height of the patient. 4 baPWV on each side was calculated as the transmission distance divided by transmission time. For analysis, the higher values of baPWV and brachial blood pressures (systolic, diastolic, and mean arterial pressure) on both sides were used. Mean arterial pressure was calculated by adding the systolic pressure to 2× diastolic pressure and dividing the total by 3. Ankle-brachial index was calculated as the lower measurement of systolic pressure in the legs divided by the higher measurement of systolic pressure in the arms.
Clinical Variables and Risk Factors
Initial stroke severity was determined based on the National Institutes of Health Stroke Scale (NIHSS) score at admission. We collected baseline characteristics for sex, age, hypertension, diabetes mellitus, hypercholesterolemia, current smoking, atrial fibrillation, congestive heart failure, coronary artery diseases, peripheral artery disease, cerebral artery atherosclerosis, previous stroke (ischemic or hemorrhagic), use of thrombolysis at admission (intravenous or intraarterial), stent insertion, or endarterectomy in cerebral artery. The presence of atrial fibrillation, congestive heart failure, or coronary artery disease is grouped into 1 variable (cardiac disease). Cerebral artery atherosclerosis was defined as occlusion or significant stenosis (≥50%) of any intracranial or extracranial cerebral artery based on an angiographic study (digital subtraction angiography, magnetic resonance angiography, or computed tomographic angiography). Stroke subtypes were classified using the TOAST classification. 16 We also collected laboratory data at admission and data for medications used before and during the admission (Table 1) .
Survival Data
The primary outcomes analyzed in this study were all-cause death and vascular death. The date and cause of death were identified using death certificates from the Korean National Statistical Office. Patients who were alive on December 31, 2012, were censored. In few patients whose fate remains unknown with the data of the Korean Data are n (%), mean±SD, or median (interquartile range). baPWV indicates brachial-ankle pulse wave velocity; and NIHSS, National Institutes of Health Stroke Scale.
*The presence of cardiac disease is defined when a patient has atrial fibrillation, congestive heart failure, or coronary artery disease. 18 The cause of death was coded according to the International Classification of Diseases, Tenth Revision. Death was categorized into vascular death and nonvascular death, and vascular death was defined as death because of heart diseases (I20-I25, I30-I52), cerebrovascular diseases (I60-I69), or diseases of arteries, arterioles, and capillaries (I70-I79). Nonvascular death was treated as a competing risk of vascular death.
Statistical Analysis
Patients were subdivided into tertile groups (T1-T3) according to the level of baPWV. In survival analyses for vascular mortality, a competing risks approach was used. Between tertile groups of baPWV, survival probability was compared using log-rank test for all-cause mortality and Gray test of the cumulative incidence functions for vascular mortality. We illustrated stacked cumulative incidence plots including vascular and nonvascular deaths based on the cumulative incidence functions. 19 To assess the effect of variables on survival, hazard ratio (HR) and 95% confidence interval (CI) were computed by standard Cox hazard regression for all-cause mortality and cause-specific Cox hazard regression for vascular mortality (nonvascular death was censored at the event time). The assumption of proportional hazards for baPWV was tested. In multivariate models, adjustments were performed for sex, age, and variables that showed a P<0.10 in the univariate analyses. To avoid the multicollinearity problem, use of medication was not included in the final model. For the same reason, adjustment for each blood pressure (systolic, diastolic, and mean) was examined in separate models. In addition to the tertile groups of baPWV, we also treated the value of baPWV as a continuous variable (m/s) or a dichotomized variable at an optimal cut-off value based on the maximally selected rank statistics. 20 To know the additional prognostic effect of baPWV, we computed C-statistics, continuous net reclassification improvement, and integrated discrimination improvement of Cox regression models, which are measures of improvement in model performance with censored survival data. 21, 22 To validate the prognostic value of baPWV for mortality and to identify the important risk factors for survival, we constructed random survival forest models with all collected variables. 23 Random survival forest is a nonparametric model for the analysis of right-censored survival data and is consistently better than, or at least as good as, Cox hazard regression with respect to survival prediction. 24 The random survival forest analyses provide measures of variable importance and minimal depth for each variable, which enable the determination of important risk factors in predicting survival. For a variable, a larger variable importance and a smaller minimal depth mean that the variable is more predictive in the survival model. 25 All statistical analyses were performed using R software for Windows (version 3.0.2; R Foundation for Statistical Computing, Vienna, Austria). A 2-sided P value <0.05 was considered statistically significant.
Additional information for definitions of vascular risk factors, stroke subtypes, management of stroke, and statistical methods is provided in the online-only Data Supplement.
Results
During the study period, 3207 patients with acute ischemic stroke were registered to the Yonsei Stroke Registry. After eliminating 614 patients according to the exclusion criteria, there were 2593 candidates for this study. Of these, 1765 patients who had completed baPWV measurement were finally included (Figure 1) . The excluded 828 patients who lacked baPWV were older, had higher NIHSS scores at admission, and more frequently had hypertension, cardiac disease, cerebral artery atherosclerosis, and previous stroke compared with included patients. Current smoking was less frequent in the excluded patients (Table S1 in the online-only Data Supplement).
Baseline Characteristics
The mean age was 65.10±12.05 years, and 62.15% were men ( Table 1 ). The mean value of baPWV was 21.05±6.19 m/s. The median time of baPWV measurement was hospital day 3 (interquartile range, 2-4) after admission. Across the tertile groups of baPWV (Table S2 ), higher baPWV was associated with female sex, older age, higher NIHSS score, higher blood pressures, presence of hypertension, diabetes mellitus, cardiac disease, peripheral artery disease, cerebral artery atherosclerosis, or previous stroke, and higher levels of serum glucose or creatinine. Current smoking and levels of hemoglobin and albumin were negatively associated with baPWV. The hospital day of baPWV measurement did not differ by baPWV.
Association of baPWV With Mortality
The mean follow-up period was 3.33±1.57 years (median, 3.18; interquartile range, 2.08-4.63). There were 228 all-cause deaths including 143 vascular deaths during follow-up (Table  S3 ). Figure 2 presents stacked cumulative incidence plots for all-cause and vascular deaths. Across the tertile groups of baPWV, patients with higher baPWV were at increased risk for all-cause death and vascular death (both P<0.001). In univariate and multivariate Cox hazard regression models, we found a significant stepwise increased risk for all-cause and vascular mortality across the tertile groups of baPWV ( Table 2 ). The proportional hazard assumption was satisfied for baPWV (P>0.05). There was no significant change on estimates of baPWV with additional adjustments for the hospital day of baPWV measurement, medications used before and during the admission, or other components of blood pressures. From the maximally selected rank statistics, the optimal cutoff points of baPWV were >27.48 m/s for all-cause mortality and >28.56 m/s for vascular mortality ( Figure S1 ). The positive association between baPWV and mortality remained significant when we treated baPWV as a continuous variable or dichotomized baPWV based on the optimal cut-off point. HR Tables S4 and S5 . When we applied subdistribution hazards model proposed by Fine and Gray for competing risk analysis, baPWV also has a significant effect on vascular mortality (Table S6 ).
In subgroup analyses by sex and stroke subtypes, the prognostic effect of baPWV was retained (Table S7 ). We could not find significant interaction between sex or the stroke subtype and baPWV in the survival analyses (P>0.05). There was a concern that the measurement of baPWV might be inaccurate in patients with ankle-brachial index <0.95 or with cardiac arrhythmia including atrial fibrillation. 6 When we performed a subgroup analysis (n=1266) after excluding the patients with those conditions, each 10 m/s increase in baPWV was also significantly associated with higher all-cause mortality (adjusted HR, 2.13; 95% CI, 1.39-3.25) and vascular mortality (adjusted HR, 2.11; 95% CI, 1.35-3.29).
Comparison of Model Performance With and Without baPWV
Compared with models with sex, age, and NIHSS score at admission, the addition of baPWV significantly increased the C-statistics for both all-cause and vascular mortality (Table 3 ). In addition, continuous net reclassification improvement and integrated discrimination improvement were positive although integrated discrimination improvement was not significant. These findings suggested the additional prognostic value of baPWV after acute stroke.
Random Survival Forest Analyses
When we performed random survival forest analyses, there was a dose-response relationship between the value of baPWV and all-cause/vascular mortality ( Figure S2 ). Based both on variable importance (higher is predictive) and minimal depth (lower is predictive), baPWV was one of the most important baPWV indicates brachial-ankle pulse wave velocity; CI, confidence interval; and HR, hazard ratio . *Derived from cause-specific Cox hazard regression model (nonvascular death is censored at the event time). †Adjusted for sex, age, National Institutes of Health Stroke Scale (NIHSS) score at admission, hypertension, diabetes mellitus, current smoking, cardiac disease, peripheral artery disease, cerebral artery atherosclerosis, previous stroke, stroke subtype, hemoglobin, cholesterol, low-density lipoprotein, triglyceride, albumin, glucose, creatinine, and diastolic arterial pressure.
‡Adjusted for sex, age, NIHSS score at admission, current smoking, cardiac disease, peripheral artery disease, cerebral artery atherosclerosis, previous stroke, stroke subtype, white blood cell count, hemoglobin, cholesterol, triglyceride, albumin, creatinine, and diastolic arterial pressure.
§HR in patients with baPWV above the optimal cut-off point (>27.48 m/s for all-cause mortality and >28.56 m/s for vascular mortality) compared with those with baPWV less than the cut-off point.
║HR per increase in 10 m/s of baPWV. Figure 2 . Stacked cumulative incidence curves of patients with stroke according to the brachial-ankle pulse wave velocity (baPWV). The probability was estimated based on cumulative incidence functions. All-cause mortality is identical to the sum of vascular and nonvascular mortality. Across the tertile groups of baPWV (A-C), there is a significant stepwise increased risk for all-cause and vascular mortality (both P<0.001).
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predictors for all-cause and vascular mortality, along with age and NIHSS score at admission (Figure 3 ).
Discussion
We found that a higher baPWV was independently associated with all-cause and vascular mortality in patients with acute ischemic stroke. There were only few studies for the prognostic value of PWV in acute phase of stroke. Higher cfPWV in patients with acute stroke was associated with less early improvement in stroke severity and worse long-term functional outcome. 11, 12 One study demonstrated that higher baPWV in acute stroke was a worse prognostic marker for progressive neurological deficits. 13 We added an evidence that baPWV measured in acute stroke also has a predictive value for mortality.
Although cfPWV is considered to be the gold standard marker of central artery stiffening, baPWV is an indicator of the combination of central and peripheral arterial stiffness. 8, 26 Contrary to central elastic arteries, peripheral arteries do not appear to change significantly with aging and disease states. 6, 17 However, many clinical studies demonstrated that both baPWV and cfPWV exhibit similar association with established vascular risk factors and the presence of systemic atherosclerosis. 4, 6, 27 Several longitudinal studies and metaanalysis proved that the prognostic value of baPWV is significant as like cfPWV. 8, 10 Recently, the clinical roles of peripheral artery stiffness have been increasingly recognized. 26, 28 Several mechanisms may be responsible for the increased risk of mortality in patients with acute stroke with higher baPWV. Higher PWV means stiffening of the artery and reflects the presence and severity of underlying cerebral or systemic atherosclerosis, both of which relate to increased mortality and morbidity after stroke. 3, 27 Arterial stiffness has been suggested as not only a marker of atherosclerosis but also a modulator for progression of atherosclerosis and development of hypertension. 7, 29 A stiffened artery is a cause of premature return of reflected waves in late systole, increasing pulse pressure. 1 Transmission of increased pulsatile stress leads to stretch, necrosis, hypertrophy, fibrosis, calcification, and remodeling of vessel wall. 30 Increase in stiffness of the Higher PWV is also related to end-organ damage in addition to arterial damage. 3 There are accumulating evidence including longitudinal studies for the significant association between higher baPWV or cfPWV and myocardial hypertrophy, impaired coronary perfusion, renal impairment, and microvascular brain damage, which could contribute to the increased all-cause and vascular mortality. 2, 3, 32 The brain is a high-bloodflow organ and particularly susceptible to increased pulsatile pressure by low vascular resistance. 30 Increased artery stiffness is also associated with dysfunction of vasoregulatory mechanisms and blunted microvascular reactivity to ischemic stress, which may aggravate cerebral ischemic damage. 33 There are many other conditions associated with arterial stiffness such as enhanced inflammation, endothelial dysfunction, and oxidative stress. 5, 13 These conditions could be determinants or surrogate markers for poor clinical outcome after stroke.
This study has strength of relatively large number of patients, and our database contained detailed information on initial stroke severity, traditional risk factors, cardiac diseases, lipid profile, and extensive workup for systemic atherosclerosis, including cerebral angiography and ankle-brachial index. We demonstrated that baPWV was one of the strongest predictors for mortality after stroke, and baPWV could improve risk prediction. There are also some potential limitations. This was a retrospective, single-center study with Asian patients with stroke. There were some patients who did not undergo measurement of baPWV during the study period. Study patients had characteristics of high prevalence of cerebral artery atherosclerosis and mild stroke severity; these features might cause selection bias. There were many right-censoring data because included patients had relatively recent stroke onset, which interrupted more long-term follow-up. External validation study is necessary to ensure the prognostic effect of baPWV on acute stroke. There is criticism for baPWV that the pulse wave does not travel directly from the brachial arteries to the posterior tibial arteries in the same arterial tree. 4, 17 The measurement of baPWV was performed once during admission. Longitudinal serial measurements for baPWV during follow-up might be helpful to better determine the pathophysiologic role of baPWV on prognosis. By the limitation of observational design, we could not conclude whether higher baPWV contributed to increased mortality or was a surrogate marker of other established risk factors. Additional study is needed to evaluate the potential preventive effect of interventions that can reduce arterial stiffness, such as regular exercise, lipid-lowering agents, and some classes of antihypertensives. 5 Other limitations were the lack of data on nonfatal events such as recurrent vascular events, which might have provided further information to understand the mechanisms of high baPWV-mortality association.
Perspectives
baPWV has a strong prognostic value for all-cause and vascular mortality after acute ischemic stroke. Our findings suggest that elevated arterial stiffness during acute phase of vascular events may be used as a potent marker to identify patients at an increased risk of long-term poor outcomes. What Is New?
Sources of Funding
• During acute phase of ischemic stroke, measurement of brachial-ankle pulse wave velocity has a prognostic value for all-cause and vascular mortality.
What Is Relevant?
• In acute phase of vascular events, measurement of brachial-ankle pulse wave velocity is of value to predict long-term mortality.
Summary
Brachial-ankle pulse wave velocity is an independent prognostic factor of mortality in patients with acute ischemic stroke.
Expanded Methods
Definition of risk factors
Hypertension was diagnosed when a patient was on antihypertensive medication or had systolic blood pressures of ≥140 mmHg or diastolic blood pressures of ≥90 mmHg on repeated measurements during the admission. Diabetes mellitus was diagnosed if the patient had a fasting plasma glucose level of ≥7.0 mmol/L or was being treated with antidiabetic medications or insulin. Hypercholesterolemia was diagnosed if the patient had a low-density lipoprotein cholesterol level of ≥4.1 mmol/L, total cholesterol level of ≥6.2 mmol/L, or was being treated with lipid-lowering agents after a diagnosis of hypercholesterolemia. Current smoking was defined as having smoked a cigarette in the year prior to admission. Congestive heart failure was defined based on the Framingham criteria. 1 The presence of coronary artery disease was identified when a patient had a history of acute myocardial infarction, unstable angina, angiographically confirmed coronary artery occlusive disease (stenosis ≥50%), coronary artery bypass graft, or percutaneous coronary artery stent/angioplasty. The presence of peripheral artery disease was determined if a patient had an ankle-brachial index <0.9 on either the right or left side measured by VP-1000 (Colin Co. Ltd, Komaki, Japan) during admission. Cerebral artery atherosclerosis was defined as occlusion or significant stenosis (≥50%) of any intracranial or extracranial cerebral artery based on cerebral angiographic study. The presence of cerebral artery atherosclerosis was assessed in the anterior cerebral artery, middle cerebral artery, posterior cerebral artery, basilar artery, internal carotid artery, and vertebral artery. Included patients underwent at least one of cerebral angiographic study using digital subtraction angiography (DSA), magnetic resonance angiography (MRA), or computed tomographic angiography (CTA). For those patients who received both DSA and MRA or CTA, the results of the DSA were used for analysis. MRA was conducted using a 3.0-T system (Achieva, Philips, Best, the Netherlands, or Trio, Siemens, Erlangen, Germany). CTA was performed with the 64-slice CT scanner (Siemens Sensation 64, Siemens Medical Solutions, Forchheim, Germany). The degree of stenosis in the extracranial cerebral artery was measured using the method in the North American Symptomatic Carotid Endarterectomy Trial, 2 and that in the intracranial cerebral artery was measured using the method in the Warfarin vs. Aspirin for Symptomatic Intracranial Disease Trial. 3 All angiographic findings were evaluated and determined during the weekly stroke conference based on the consensus of stroke specialists and on the radiology report, and were prospectively registered in the Yonsei stroke registry. 4 Stroke subtypes Study patients were classified into small vessel occlusion, large artery atherosclerosis, cardioembolism, and undetermined etiology based on the Trial of Org 10172 in Acute Stroke Treatment classification. 5 Patients who had rare causes of stroke, classified to other determined etiology, were excluded from this study. Briefly, the patients with relevant steno-occlusive lesion (≥50%) in large cerebral artery are classified into large artery atherosclerosis. If the patients have at least one potential cardiac source of embolism, cardioembolism is considered. Small vessel occlusion is defined when the patients has classical lacunar syndrome and a relevant small (<15mm) subcortical hemispheric or brain stem ischemic lesion. Undetermined etiology is defined when the patients have no likely etiology or more than two etiologic features.
Management for stroke
Patients were treated according to standard treatment protocols in our hospital based on the guidelines for stroke. 6, 7 Patients admitted within 6 hours after stroke onset were considered for intravenous tissue-type plasminogen activator, intra-arterial thrombolysis, or combined intravenous and intraarterial thrombolysis, according to our thrombolysis protocol. 8 Stent insertion or endarterectomy was performed in selected patients for stroke prevention according to the guidelines. 7 Patients with a highrisk for potential cardiac sources of embolism, such as atrial fibrillation, intracardiac thrombus, and mechanical prosthetic valve, received anticoagulation. 7 Others received antiplatelet agents, unless there was a contraindication to antithrombotic medication. Early rehabilitation was strongly encouraged for patients with neurological deficits.
Statistical methods
Inter-group differences were compared using Fisher's exact test, independent t-test, one-way analysis of variance, Mann-Whitney U test or the Kruskal-Wallis test. The National Institute of Health Stroke Scale scores were considered to be a continuous variable.
To estimate effect of brachial-ankle pulse wave velocity (baPWV) on vascular mortality, we used a competing risk approach. Comparison of cumulative incidence of vascular death was performed using Gray's test. 9 Gray's test is identical to log-rank test in the absence of competing risk. Estimation of cumulative incidence at certain time-point was obtained using the method proposed by Choudhurt. 10, 11 Cause-specific hazard ratio was estimated using Cox proportional hazard regression model with censoring patients with competing risk at the event time. The subdistribution hazards ratio was calculated using the method of Fine and Gray.
12, 13 The analyses for competing risk were performed using the R-package of 'cmprsk'. 14, 15 The maximally selected rank statistics was adapted to determine which cut-off point of baPWV best segregated patients into poor and good prognosis subgroups (in terms of likelihood of survival). [16] [17] [18] The log-rank test was used to measure the strength of the grouping. The range between the 5% and the 95% percentile of baPWV was used as a selection interval for the optimal cut-off point. To determine a P value that would be interpreted as a measure of the strength of the association based on the maximally selected rank statistics, 10000 conditional Monte-Carlo simulations were performed to estimate the distribution of the maximally selected rank statistics under the hypothesis of no association. 17 The maximally selected rank statistics was calculated using the 'maxstat' R package. 19 To assess improvement of model performance by addition of baPWV, we calculated C-statistic, continuous net classification improvement and integrated discrimination improvement between Cox models with and without baPWV. [20] [21] [22] Comparisons of the models were interfered using the R packages of 'survC1' and 'survIDINRI', and iteration of perturbation-resampling was done for 1000 times. 23, 24 Random survival forest (RSF) analyses were performed to validate the prognostic value of baPWV and identify important risk factors in predicting survival in patients with acute stroke. RSF were implemented using the 'randomForestSRC' R-package. 25 RSF analyses construct numerous survival trees from bootstrap samples of original data with randomly selected covariates. 26 Each tree is grown on a bootstrap sample of the original data. At the each branch, a random set of variables is chosen to be candidates, and the variable maximizing the log-rank statistic is selected to split the branch into 2 other branches. 27 We computed "variable importance" (VIMP) and "minimal depth" for each variable. VIMP of a variable is calculated as the difference between the prediction error from the original data including the variable and that obtained from the data permutated for the variable. 28 Minimal depth of a variable is the depth at which the variable first splits within a tree, relative to the root node. 29 The most predictive variables are those whose minimal depth (averaged over the forest) is smaller than a threshold value determined under the null hypothesis that a variable is unrelated to the survival distribution. 30 For vascular mortality, we performed RSF models for competing risks (vascular death is event of interest and non-vascular death is treated as a competing risk). A modified weighted logrank splitting rule was implemented for competing risk analysis. An RSF is generated by creating 2000 trees. Otherwise, default options were used for RSF analyses. Figure S1 . The standardized statistic of integer valued log-rank scores as a function of the optimal cut-off point of brachial-ankle pulse wave velocity. The optimal cut-off point of baPWV maximizing the log-rank statistics is indicated by the dashed line (>27.48 m/sec for (A) all-cause mortality and >28.56 m/sec for (B) vascular mortality). baPWV indicates brachial-ankle pulse wave velocity. Figure S2 . Predicted probability of all-cause death (A, B, C) and cumulative incidence of vascular death (D, E, F) for the top 3 variables on random survival forest analyses. Patients who die are indicated in blue dots. The red lines are predicted probability of all-cause death and cumulative incidence of vascular death at the median survival time (3.18 years). The x-axes are limited from 5th to 95th percentile of the variables. baPWV indicates brachial-ankle pulse wave velocity; NIHSS, National Institutes of health Stroke Scale.
